Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6680-6684
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6680
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6680
Table 1 Demographic and disease characteristics of patients with irritable bowel syndrome at baseline n (%)
| Males | 5 (26) |
| Median age at inclusion, yr (range) | 35 (18-74) |
| IBS subtype | |
| IBS-D, diarrhoeal | 8 (42) |
| IBS-C, constipating | 4 (21) |
| IBS-A, alternating | 7 (37) |
| Abdominal surgery before study | 4 (21) |
| Appendectomy | 2 (11) |
| Hysterectomy | 1 (5) |
| Laparoscopy | 1 (5) |
| IBS medication at baseline | 7 (37) |
| Antidepressivum ± laxativum | 4 (50) |
| Laxativum ± spasmolyticum | 3 (38) |
| Smoking status | |
| Never | 11 (58) |
| Former | 7 (37) |
| Currently | 1 (5) |
| Median BMI (range) | 22 (17-27) |
- Citation: Pedersen N, Vegh Z, Burisch J, Jensen L, Ankersen DV, Felding M, Andersen NN, Munkholm P. Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol 2014; 20(21): 6680-6684
- URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6680.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6680